211 filings
Page 8 of 11
8-K
tgzvw3
2 Nov 18
Checkpoint Therapeutics Reports Third Quarter 2018 Financial Results and Recent Corporate Highlights
8:33am
8-K
xrroj b4yoy2b
16 Oct 18
Checkpoint Therapeutics Appoints Christian Béchon to its Board of Directors
5:01pm
8-K
9fi34
6 Sep 18
Checkpoint Therapeutics Announces Encouraging Safety and Efficacy Data from Phase 1/2 Clinical Trial of EGFR Inhibitor CK-101
12:00am
8-K
l49i7utb a0158g
8 Aug 18
Checkpoint Therapeutics Reports Second Quarter 2018 Financial Results and Recent Corporate Highlights
12:00am
8-K
d9eykav19czv
14 Jun 18
Submission of Matters to a Vote of Security Holders
12:00am
8-K
9rq951750ghz7lollbg
10 May 18
Checkpoint Therapeutics Reports First Quarter 2018 Financial Results and Recent Corporate Highlights
4:43pm
DEFA14A
wg6q7mnxtuq7y5e i7
30 Apr 18
Additional proxy soliciting materials
7:02am
PRE 14A
tvgbrh1d
20 Apr 18
Preliminary proxy
12:00am
8-K
sry8b9mk8g06 zopl
15 Mar 18
Checkpoint Therapeutics Reports Fourth Quarter and Full-Year 2017 Financial Results and Recent Corporate Highlights
12:00am
8-K
01bxlhyiaaay9x
8 Mar 18
Entry into a Material Definitive Agreement
12:00am
424B5
dqip y24gj
8 Mar 18
Prospectus supplement for primary offering
12:00am
424B5
ryroaj9b je67pajb
7 Mar 18
Prospectus supplement for primary offering
12:00am
8-K
2zta86vrlrhi6asow5ac
4 Dec 17
Other Events
12:00am
EFFECT
ktp7lfjyccr9 r560
1 Dec 17
Notice of effectiveness
12:00am
CORRESP
383q0dtbmza
29 Nov 17
Correspondence with SEC
12:00am